Found: 28
Select item for more details and to access through your institution.
Phase 1b investigation of the MEK inhibitor binimetinib in patients with advanced or metastatic biliary tract cancer.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 6, p. 1037, doi. 10.1007/s10637-018-0600-2
- By:
- Publication type:
- Article
Sharing a love of life with Auntie Katie.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Services must focus on gaining communities' trust.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
The Forkhead Box M1 protein regulates BRIP1 expression and DNA damage repair in epirubicin treatment.
- Published in:
- Oncogene, 2013, v. 32, n. 39, p. 4634, doi. 10.1038/onc.2012.491
- By:
- Publication type:
- Article
A randomized, phase II trial of oral azacitidine (CC-486) in patients with resected pancreatic adenocarcinoma at high risk for recurrence.
- Published in:
- Clinical Epigenetics, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13148-022-01367-8
- By:
- Publication type:
- Article
Utilization of Quantitative In Vivo Pharmacology Approaches to Assess Combination Effects of Everolimus and Irinotecan in Mouse Xenograft Models of Colorectal Cancer.
- Published in:
- PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0058089
- By:
- Publication type:
- Article
The Many Faces of Wnt and Pancreatic Ductal Adenocarcinoma Oncogenesis.
- Published in:
- Cancers, 2011, v. 3, n. 3, p. 3676, doi. 10.3390/cancers3033676
- By:
- Publication type:
- Article
A phase I study of sorafenib and vorinostat in patients with advanced solid tumors with expanded cohorts in renal cell carcinoma and non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 1, p. 115, doi. 10.1007/s10637-012-9812-z
- By:
- Publication type:
- Article
Patient-Reported Outcomes, Tumor Markers, and Survival Outcomes in Advanced GI Cancer.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 11, p. e2343512, doi. 10.1001/jamanetworkopen.2023.43512
- By:
- Publication type:
- Article
Leveraging patient‐reported outcomes (PROs) in patients with pancreatic cancer: The Pancreatic Cancer Action Network (PanCAN) online patient registry experience.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 20, p. 7152, doi. 10.1002/cam4.4257
- By:
- Publication type:
- Article
La(iii) biodistribution profiles from intravenous and oral dosing of two lanthanum complexes, La(dpp)<sub>3</sub> and La(XT), and evaluation as treatments for bone resorption disorders.
- Published in:
- Metallomics, 2017, v. 9, n. 7, p. 902, doi. 10.1039/c7mt00133a
- By:
- Publication type:
- Article
A phase 1 dose-escalation and expansion study of binimetinib (MEK162), a potent and selective oral MEK1/2 inhibitor.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase I study of the anti-α5β1 monoclonal antibody MINT1526A with or without bevacizumab in patients with advanced solid tumors.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A phase 1b study of erlotinib in combination with gemcitabine and nab-paclitaxel in patients with previously untreated advanced pancreatic cancer: an Academic Oncology GI Cancer Consortium study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The efficacy and safety of cardio-protective therapy in patients with 5-FU (Fluorouracil)-associated coronary vasospasm.
- Published in:
- PLoS ONE, 2022, v. 17, n. 4, p. 1, doi. 10.1371/journal.pone.0265767
- By:
- Publication type:
- Article
A Phase I Study of Dinaciclib in Combination With MK‐2206 in Patients With Advanced Pancreatic Cancer.
- Published in:
- CTS: Clinical & Translational Science, 2020, v. 13, n. 6, p. 1178, doi. 10.1111/cts.12802
- By:
- Publication type:
- Article
Phase 2 trial of concurrent bevacizumab and transhepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 5, p. 1042, doi. 10.1002/cncr.27859
- By:
- Publication type:
- Article
A Phase I Dose‐Escalation Study of Linsitinib (OSI‐906), a Small‐Molecule Dual Insulin‐Like Growth Factor‐1 Receptor/Insulin Receptor Kinase Inhibitor, in Combination with Irinotecan in Patients with Advanced Cancer.
- Published in:
- Oncologist, 2018, v. 23, n. 12, p. 1409, doi. 10.1634/theoncologist.2018-0315
- By:
- Publication type:
- Article
In patients' interests.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Postcode lottery means a long trip for return-to-practice nurses.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Nurses given power to remove antisocial patients and relatives.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Lung cancer services audit points to value of specialist practitioners.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Investing in the future.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
New act, new ethos, new role.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
The business of diversity.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Associations of baseline patient‐reported outcomes with treatment outcomes in advanced gastrointestinal cancer.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 4, p. 619, doi. 10.1002/cncr.33315
- By:
- Publication type:
- Article
Tumor Microenvironment Immune Response in Pancreatic Ductal Adenocarcinoma Patients Treated With Neoadjuvant Therapy.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article